US EditionPublished • loading... • Updated
Risk Score Helps Predict Pancreatic Cancer Recurrence, Study Says
The score stratifies patients into risk groups to guide monitoring, showing about 10% of node-negative patients may face recurrence, mostly in the liver, researchers said.
- On Dec. 17, researchers reported in JAMA Surgery that a 13-point risk score predicts which pancreatic cancer survivors are likelier to have recurrence, according to a Cedars‑Sinai Medical Center news release.
- A 91% five-year survival rate masks a subset at higher risk, as current clinical guidelines leave clinicians with a one-size-fits-all approach, senior researcher Dr. Cristina Ferrone said.
- Using data from 770 pancreatic cancer patients across five major hospitals, researchers developed the score based on four key factors including male sex and tumor size of 3 centimeters or larger.
- The score could help better manage follow-up care for patients with surgically removed pancreatic tumors whose cancer hasn’t spread to lymph nodes, as about 10% still face recurrence, most often in the liver.
- Results could influence future guideline development for individualized and cost-effective care, addressing a critical gap, researchers said, with Dr. Cristina Ferrone noting it offers meaningful change opportunities.
Insights by Ground AI
19 Articles
19 Articles
Coverage Details
Total News Sources19
Leaning Left5Leaning Right2Center3Last UpdatedBias Distribution50% Left
Bias Distribution
- 50% of the sources lean Left
50% Left
L 50%
C 30%
R 20%
Factuality
To view factuality data please Upgrade to Premium
